Tag: FDA
Complex Generic Formulations: Why Proving Bioequivalence Is So Hard
Proving bioequivalence for complex generics like inhalers, creams, and injectables is far harder than for simple pills. Learn why standard tests fail, how reverse-engineering works, and what’s being done to bring affordable versions to market.